Evidence map›Paper›PMID 39127839›Full record

ArticleScientific reports2024

Neuromuscular dysfunction and pathogenesis in triosephosphate isomerase deficiency.

Tracey D Myers, Yizhi Li, Stefanie Taiclet, Paulina Cabada-Aguirre, Emily Kuti, Kaitlin McClure, Christopher Blanchard, Marta Wolosowicz, Gregg E Homanics, Adam C Straub and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Tracey D MyersCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Yizhi LiCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Stefanie TaicletDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Paulina Cabada-AguirreCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Emily KutiDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Kaitlin McClureDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Christopher BlanchardDepartment of Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA.
Marta WolosowiczDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Gregg E HomanicsCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Adam C StraubDepartment of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, PA, USA.
Stephen D MerineyCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA.
Michael J PalladinoCenter for Neuroscience at the University of Pittsburgh, Pittsburgh, PA, USA. mjp44@pitt.edu.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Role of noncoding RNA in alcohol actionU01AA020889 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sean P Farris, Gregg E. Homanics · 2011 to 2026
$7.1M
Basic and Translational Studies in Redox Regulation of Cardiovascular Physiology and DiseaseR35HL161177 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Adam Carl Straub · 2022 to 2026
$4.7M
High-content screening for TPI Deficiency therapeuticsR01HD104346 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN, VOGT, ANDREAS · 2021 to 2025
$2.8M
Developing the first TPI Df therapeuticsR01HD105311 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN, VOGT, ANDREAS · 2021 to 2025
$2.7M
Predoctoral Training in Pharmacological Sciences (Resubmission)T32GM133332 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Tija C. Jacob, Francisco Jose Schopfer · 2020 to 2026
$1.8M
Advanced High Resolution Rodent Ultrasound Imaging SystemS10OD023684 · OD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIM, KANG · 2018 to 2018
$390k
Developing a murine TPI Df modelR03NS119664 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PALLADINO, MICHAEL JOHN · 2021 to 2021
$158k
NCI NIH HHS P30 CA047904NHLBI NIH HHS R35 HL161177NIAAA NIH HHS U01 AA020889NICHD NIH HHS R01 HD104346NICHD NIH HHS R01 HD105311NIGMS NIH HHS T32 GM133332NIH HHS R03 NS119664NIH HHS R35HL 161177NIH HHS S10 OD023684NIH HHS T32 GM133332NIH HHS U01 AA020889NINDS NIH HHS R03 NS119664
6 · The paper itself

Abstract

Triosephosphate isomerase deficiency (TPI Df) is a rare multisystem disorder with severe neuromuscular symptoms which arises exclusively from mutations within the TPI1 gene. Studies of TPI Df have been limited due to the absence of mammalian disease models and difficulties obtaining patient samples. Recently, we developed a novel murine model of TPI Df which models the most common disease-causing mutation in humans, TPI1

Indexed as

Disease Models, AnimalNeuromuscular JunctionTriose-Phosphate IsomeraseAnemia, Hemolytic, Congenital NonspherocyticAnimalsCarbohydrate Metabolism, Inborn ErrorsHumansMiceMutationNeuromuscular DiseasesTriose-Phosphate Isomerase

Identifiers

PMID39127839
PMCPMC11316810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.